14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Jun 23, 2026
ABVE vs DEVS: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Jun 23, 2026, Above Food Ingredients Inc. (ABVE) is the stronger overall head-to-head candidate over DevvStream Corp. (DEVS) in the Tradestie Institutional Equity Comparison Engine, winning 4–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). ABVE carries a Unified Composite Score of 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin), whereas DEVS carries 52.5/100 (HOLD) at $0.15 (N/M Forward P/E, -297014.7% operating margin).
Composite vs. Pillar Nuance: While DEVS currently prints a higher short-term Unified Composite Score (52.5/100 HOLD vs. ABVE 39.8/100 SELL), ABVE captures the overall institutional head-to-head verdict (4–3 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (-23.2% vs. -297014.7% operating margin) and revenue trajectory (-45.0% vs. -92.9% YoY).
Technical & Structure Timing Caution: ABVE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0); meanwhile DEVS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVE vs DEVS. Trailing 12-month operating profitability (ABVE -23.2% vs DEVS -297014.7%) and valuation multiples (ABVE N/M vs DEVS N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Pollution & Treatment Controls value chain with $7.6M market capitalization and -297014.7% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ ABVE vs DEVS Key Questions & Quantitative Answers
As of Jun 23, 2026, Above Food Ingredients Inc. (ABVE) is the stronger overall head-to-head candidate over DevvStream Corp. (DEVS) in the Tradestie Institutional Equity Comparison Engine, winning 4–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). ABVE carries a Unified Composite Score of 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin), whereas DEVS carries 52.5/100 (HOLD) at $0.15 (N/M Forward P/E, -297014.7% operating margin). Composite vs. Pillar Nuance: While DEVS currently prints a higher short-term Unified Composite Score (52.5/100 HOLD vs. ABVE 39.8/100 SELL), ABVE captures the overall institutional head-to-head verdict (4–3 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (-23.2% vs. -297014.7% operating margin) and revenue trajectory (-45.0% vs. -92.9% YoY). Technical & Structure Timing Caution: ABVE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0); meanwhile DEVS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ABVE leads the Growth & Scale pillar: ABVE posts -45.0% YoY revenue growth and +0.0% YoY earnings growth on $295M TTM revenue (-2.8% gross margin, -23.2% operating margin), compared with DEVS at -92.9% YoY revenue growth and +0.0% YoY earnings growth on $24,493 TTM revenue (27.8% gross margin, -297014.7% operating margin). On trailing 12-month operating scale, ABVE generates $295M in USD-normalized revenue versus $24,493 for DEVS. In operating R&D and SG&A reinvestment, ABVE deploys 20.4% of Rev ($60M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for DEVS.
ABVE screens cheaper on headline valuation multiples. ABVE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-13.7% EBITDA margin), whereas DEVS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ABVE (0.0% ROE) versus DEVS (0.0% ROE) capital efficiency.
In options market volatility and institutional positioning, ABVE carries 148.3% implied volatility (8th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (4.10β · 310% Vol realized risk). By comparison, DEVS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.10β · 605% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Jun 23, 2026. For educational research only; not investment advice.